Form EFFECT Semnur Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 18, 2026 |
| Accession Number: | 0001193125-26-219654 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LAWSUIT ALERT: Investors in FS KKR Capital Corp. (NYSE: FSK) shares should contact the Shareholders Foundation
- Kudos Earns 100 G2 Badges in Fall 2026, Including 11 First-Place Finishes
- UL Research Institutes’ Alejandro Lozano Shares How to Take C.H.A.R.G.E. of Battery Safety with YourUpdateTV
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
